A Study in Healthy Men to Find the Best Formulation of BI 685509 and to Test How it is Taken up in the Body

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

February 7, 2022

Study Completion Date

February 7, 2022

Conditions
Healthy
Interventions
DRUG

R1: Reference Product X

under fasted conditions

DRUG

T1: Test Product M

under fasted conditions

DRUG

T2: Test Product N

under fasted conditions

DRUG

T3: Test Product O

under fasted conditions

DRUG

T4: Test Product O

under fed conditions

DRUG

R2: Reference Product Y

under fasted conditions

DRUG

T5: Test Product P

under fasted conditions

DRUG

T6: Test Product P

under fed conditions

DRUG

T7: Test Product Q

under fasted conditions

DRUG

R3: Reference Product Z

under fasted conditions

DRUG

T8: Test Product S

under fasted conditions

DRUG

T9: Test Product S

under fed conditions

DRUG

T10: Test Product U

under fasted conditions

Trial Locations (1)

NG11 6JS

Quotient Sciences, Nottingham

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY